Recombinant multi-species MEF2C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MEF2C protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This locus encodes a member of the MADS box transcription enhancer factor 2 (MEF2) family of proteins, which play a role in myogenesis. The encoded protein, MEF2 polypeptide C, has both trans-activating and DNA binding activities. This protein may play a role in maintaining the differentiated state of muscle cells. Mutations and deletions at this locus have been associated with severe cognitive disability, stereotypic movements, epilepsy, and cerebral malformation. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2010]
The Alternative Names of target: 5430401D19Rik,9930028G15Rik,C5DELq14.3,DEL5q14.3,MEF2C,Mef2,Mef2c,Myocyte enhancer factor 2C,Myocyte-specific enhancer factor 2C,NEDHSIL,RGD1563119
Go
to MEF2C products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP8824-Ag-1/ GM-Tg-hg-IP8824-Ag-2 | Human MEF2C protein | Human |
| GM-Tg-rg-IP8824-Ag-1/ GM-Tg-rg-IP8824-Ag-2 | Rat MEF2C protein | Rat |
| GM-Tg-mg-IP8824-Ag-1/ GM-Tg-mg-IP8824-Ag-2 | Mouse MEF2C protein | Mouse |
| GM-Tg-cynog-IP8824-Ag-1/ GM-Tg-cynog-IP8824-Ag-2 | Cynomolgus/Rhesus macaque MEF2C protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP8824-Ag-1/ GM-Tg-felg-IP8824-Ag-2 | Feline MEF2C protein | Feline |
| GM-Tg-cang-IP8824-Ag-1/ GM-Tg-cang-IP8824-Ag-2 | Canine MEF2C protein | Canine |
| GM-Tg-bovg-IP8824-Ag-1/ GM-Tg-bovg-IP8824-Ag-2 | Bovine MEF2C protein | Bovine |
| GM-Tg-equg-IP8824-Ag-1/ GM-Tg-equg-IP8824-Ag-2 | Equine MEF2C protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP8824-Ag-1/ GM-Tg-hg-IP8824-Ag-2;
GM-Tg-rg-IP8824-Ag-1/ GM-Tg-rg-IP8824-Ag-2;
GM-Tg-mg-IP8824-Ag-1/ GM-Tg-mg-IP8824-Ag-2; GM-Tg-cynog-IP8824-Ag-1/ GM-Tg-cynog-IP8824-Ag-2; GM-Tg-felg-IP8824-Ag-1/ GM-Tg-felg-IP8824-Ag-2; GM-Tg-cang-IP8824-Ag-1/ GM-Tg-cang-IP8824-Ag-2; GM-Tg-bovg-IP8824-Ag-1/ GM-Tg-bovg-IP8824-Ag-2; GM-Tg-equg-IP8824-Ag-1/ GM-Tg-equg-IP8824-Ag-2 |
| Products Name | MEF2C protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | MEF2C |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MEF2C protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.